G. Pandina, E. Daly, C. Gassmann-Mayer
May 31, 2012
Citations
0
Influential Citations
0
Citations
Quality indicators
Journal
F1000Research
Abstract
Placebo Bavisant 1mg Bavisant 3mg Bavisant 10mg OROS MPH 54mg ATOMOX 80mg n: 23 19 21 13 22 21 20 22 23 2 5 22 17 30 27 24 34 24 35 IM P R O V E M E N T Exploratory Analyses of Efficacy by Sex and Age of a Histamine3 (H3) Receptor Antagonist (Bavisant) for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder Gahan Pandina, PhD; Ella Daly, MD; Cristiana Gassmann-Mayer, PhD; Kimberly Cooper, MS *Presenting author, Janssen Research & Development, LLC, New Jersey, USA